S. Louise Phanstiel - Net Worth and Insider Trading

S. Louise Phanstiel Net Worth

The estimated net worth of S. Louise Phanstiel is at least $2 Million dollars as of 2024-04-25. S. Louise Phanstiel is the Director of Myriad Genetics Inc and owns about 112,646 shares of Myriad Genetics Inc (MYGN) stock worth over $2 Million. S. Louise Phanstiel is also the Director of Verastem Inc and owns about 16,500 shares of Verastem Inc (VSTM) stock worth over $152,460. Details can be seen in S. Louise Phanstiel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that S. Louise Phanstiel has not made any transactions after 2021-08-05 and currently still holds the listed stock(s).

Transaction Summary of S. Louise Phanstiel

To

S. Louise Phanstiel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, S. Louise Phanstiel owns 3 companies in total, including Myriad Genetics Inc (MYGN) , Verastem Inc (VSTM) , and Butterfly Network Inc (BFLY) .

Click here to see the complete history of S. Louise Phanstiel’s form 4 insider trades.

Insider Ownership Summary of S. Louise Phanstiel

Ticker Comapny Transaction Date Type of Owner
MYGN Myriad Genetics Inc 2021-08-05 director
VSTM Verastem Inc 2018-12-31 other: Former Director
BFLY Butterfly Network Inc 2021-02-12 director

S. Louise Phanstiel Latest Holdings Summary

S. Louise Phanstiel currently owns a total of 2 stocks. Among these stocks, S. Louise Phanstiel owns 112,646 shares of Myriad Genetics Inc (MYGN) as of August 5, 2021, with a value of $2 Million and a weighting of 93.04%. S. Louise Phanstiel also owns 16,500 shares of Verastem Inc (VSTM) as of June 12, 2013, with a value of $152,460 and a weighting of 6.96%.

Latest Holdings of S. Louise Phanstiel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MYGN Myriad Genetics Inc 2021-08-05 112,646 18.08 2,037,056
VSTM Verastem Inc 2013-06-12 16,500 9.24 152,460

Holding Weightings of S. Louise Phanstiel


S. Louise Phanstiel Form 4 Trading Tracker

According to the SEC Form 4 filings, S. Louise Phanstiel has made a total of 2 transactions in Myriad Genetics Inc (MYGN) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Myriad Genetics Inc is the sale of 47,881 shares on August 5, 2021, which brought S. Louise Phanstiel around $2 Million.

According to the SEC Form 4 filings, S. Louise Phanstiel has made a total of 0 transactions in Verastem Inc (VSTM) over the past 5 years. The most-recent trade in Verastem Inc is the acquisition of 4,500 shares on June 12, 2013, which cost S. Louise Phanstiel around $43,200.

Insider Trading History of S. Louise Phanstiel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

S. Louise Phanstiel Trading Performance

GuruFocus tracks the stock performance after each of S. Louise Phanstiel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by S. Louise Phanstiel is 56.63%. GuruFocus also compares S. Louise Phanstiel's trading performance to market benchmark return within the same time period. The performance of stocks bought by S. Louise Phanstiel within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how S. Louise Phanstiel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of S. Louise Phanstiel

Average Return

29.63%

Average return per transaction

Outperforming Transactions

67%

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 57.56 56.63 28.97 29.63 -1.91 -31.62
Relative Return to S&P 500(%) 54.31 50.67 16.99 6.5 -13.1 -40.05

S. Louise Phanstiel Ownership Network

Ownership Network List of S. Louise Phanstiel

No Data

Ownership Network Relation of S. Louise Phanstiel


S. Louise Phanstiel Owned Company Details

What does Myriad Genetics Inc do?

Who are the key executives at Myriad Genetics Inc?

S. Louise Phanstiel is the director of Myriad Genetics Inc. Other key executives at Myriad Genetics Inc include Chief Financial Officer Richard Bryan Riggsbee , Chief Operating Officer Nicole Lambert , and Chief Legal Officer Pamela Wong .

Myriad Genetics Inc (MYGN) Insider Trades Summary

Over the past 18 months, S. Louise Phanstiel made no insider transaction in Myriad Genetics Inc (MYGN). Other recent insider transactions involving Myriad Genetics Inc (MYGN) include a net sale of 105,000 shares made by Richard Bryan Riggsbee , a net sale of 19,617 shares made by Nicole Lambert , and a net sale of 8,638 shares made by Daniel K Spiegelman .

In summary, during the past 3 months, insiders sold 0 shares of Myriad Genetics Inc (MYGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,255 shares of Myriad Genetics Inc (MYGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,255 shares.

Myriad Genetics Inc (MYGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Myriad Genetics Inc Insider Transactions

No Available Data

S. Louise Phanstiel Mailing Address

Above is the net worth, insider trading, and ownership report for S. Louise Phanstiel. You might contact S. Louise Phanstiel via mailing address: 320 Wakara Way, Salt Lake City Ut 84108.

Discussions on S. Louise Phanstiel

No discussions yet.